IT1206501B - Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina. - Google Patents
Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina.Info
- Publication number
- IT1206501B IT1206501B IT8322171A IT2217183A IT1206501B IT 1206501 B IT1206501 B IT 1206501B IT 8322171 A IT8322171 A IT 8322171A IT 2217183 A IT2217183 A IT 2217183A IT 1206501 B IT1206501 B IT 1206501B
- Authority
- IT
- Italy
- Prior art keywords
- analgesic
- containing caffeine
- inflammatory compositions
- compositions improved
- caffeine
- Prior art date
Links
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 title abstract 6
- 230000000202 analgesic effect Effects 0.000 title abstract 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001948 caffeine Drugs 0.000 title abstract 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000004084 narcotic analgesic agent Substances 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40059782A | 1982-07-22 | 1982-07-22 | |
| US06/474,358 US4486436A (en) | 1982-07-22 | 1983-03-11 | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8322171A0 IT8322171A0 (it) | 1983-07-21 |
| IT1206501B true IT1206501B (it) | 1989-04-27 |
Family
ID=27017112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT8322171A IT1206501B (it) | 1982-07-22 | 1983-07-21 | Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4486436A (it) |
| EP (2) | EP0229022A3 (it) |
| AT (1) | ATE29965T1 (it) |
| AU (1) | AU559218B2 (it) |
| CA (1) | CA1228544A (it) |
| DE (1) | DE3373866D1 (it) |
| IT (1) | IT1206501B (it) |
| WO (1) | WO1984000490A1 (it) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4687781A (en) * | 1978-03-03 | 1987-08-18 | Endorfin, Inc. | Analgesic and anti-inflammatory compositions |
| DE3485000D1 (de) * | 1983-06-28 | 1991-10-10 | Takeda Chemical Industries Ltd | Gemahlene mischung. |
| DE3328401A1 (de) * | 1983-08-05 | 1985-02-21 | Merckle GmbH, 7902 Blaubeuren | Injizierbare loesung zur behandlung von entzuendungen |
| US5166141A (en) * | 1983-11-01 | 1992-11-24 | Scripps Clinic And Research Foundation | Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals |
| JPS60184013A (ja) * | 1984-03-01 | 1985-09-19 | Yoshitomi Pharmaceut Ind Ltd | 点眼剤 |
| JPS60209515A (ja) * | 1984-04-03 | 1985-10-22 | Hokuriku Seiyaku Co Ltd | 消炎鎮痛クリ−ム剤 |
| AU582513B2 (en) * | 1984-12-26 | 1989-03-23 | Eugene M. Laska | Method for using musculoskeletal relaxants |
| CH664085A5 (de) * | 1985-02-08 | 1988-02-15 | Ciba Geigy Ag | Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung. |
| ZA861211B (en) * | 1985-02-25 | 1987-10-28 | Lilly Co Eli | Analgesic composition |
| US4594358A (en) * | 1985-02-25 | 1986-06-10 | Eli Lilly And Company | Analgesic method |
| KR890001236B1 (ko) * | 1985-10-02 | 1989-04-28 | 화이자 인코포레이티드 | 소염제 조성물의 제조방법 |
| IT1209667B (it) * | 1985-11-12 | 1989-08-30 | Zambon Spa | Composizione effeverscente adattivita' analgesica. |
| EP0284612B1 (en) * | 1986-01-30 | 1991-07-24 | University of Utah | Treatment of bone loss |
| CH669523A5 (it) * | 1986-06-25 | 1989-03-31 | Mepha Ag | |
| US4927854A (en) * | 1987-12-24 | 1990-05-22 | Analgesic Associates | Sustained/enhanced analgesia |
| US5286751A (en) * | 1987-12-24 | 1994-02-15 | Analgesic Associates | Sustained/enhanced antipyretic response |
| DE3800301A1 (de) * | 1988-01-08 | 1989-07-20 | Rudolf Leitz | Procainhaltige salbe und ihre verwendung |
| US5175152A (en) * | 1990-09-28 | 1992-12-29 | Singh Nikhilesh N | Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form |
| US5186222A (en) * | 1991-01-07 | 1993-02-16 | Brand Randolf W | Fuel spillage control apparatus |
| JP2829794B2 (ja) * | 1991-02-08 | 1998-12-02 | エスエス製薬 株式会社 | 徐放性経口投与型プラノプロフェン製剤 |
| JPH04346928A (ja) * | 1991-05-24 | 1992-12-02 | Doujin Iyaku Kako Kk | 坐剤 |
| KR100259989B1 (ko) * | 1991-10-01 | 2000-08-01 | 모리다 가쓰라 | 서방성 마이크로캡슐 제제 및 그의 제조법 |
| AU672279B2 (en) * | 1992-12-21 | 1996-09-26 | Procter & Gamble Company, The | Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen |
| US5760095A (en) * | 1995-12-01 | 1998-06-02 | White; Hebron B. | Method and system for effecting withdrawal from caffeine dependency |
| US5648358A (en) * | 1996-03-05 | 1997-07-15 | Mitra; Sekhar | Compositions and methods for treating respiratory disorders |
| US6348216B1 (en) * | 1996-06-10 | 2002-02-19 | Knoll Pharmaceutical Company | Ibuprofen and narcotic analgesic compositions |
| US6361794B1 (en) | 1996-06-12 | 2002-03-26 | Basf Corporation | Method of making ibuprofen and narcotic analgesic composition |
| DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| RU2120284C1 (ru) * | 1997-07-25 | 1998-10-20 | Генрих Александрович Софронов | Комбинированное противовоспалительное, анальгезирующее, жаропонижающее средство |
| RS49982B (sr) | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
| US6197347B1 (en) | 1998-06-29 | 2001-03-06 | Andrx Pharmaceuticals, Inc. | Oral dosage for the controlled release of analgesic |
| US6211246B1 (en) | 1999-06-10 | 2001-04-03 | Mcneil-Ppc, Inc. | Rapidly absorbed liquid compositions |
| AU2000270300A1 (en) * | 2000-09-13 | 2002-03-26 | Isis Innovation Limited | Use of phosphodiesterase inhibitors for the treatment of anorectal disorders |
| CZ20032829A3 (cs) * | 2001-04-16 | 2005-03-16 | Tanabe Seiyaku Co., Ltd. | Heterocyklické sloučeniny |
| US8142819B2 (en) | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US8168234B2 (en) | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US7901714B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llp | Treatment modalities for autoimmune diseases |
| US8206753B2 (en) | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
| US20040115290A1 (en) | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
| US7901713B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
| DK1404331T3 (da) | 2001-07-06 | 2008-01-28 | Penwest Pharmaceuticals Co | Sustained release-formuleringer af oxymorphon |
| KR20030034171A (ko) | 2001-07-06 | 2003-05-01 | 엔도 파마슈티걸즈, 인크. | 옥시모르폰 제어 방출 제형 |
| US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
| US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
| KR20050071605A (ko) | 2002-10-21 | 2005-07-07 | 메타프로테오믹스, 엘엘씨 | 염증반응과 관련된 병리학적 상태를 치료하거나 저해하는조성물 |
| US20040209850A1 (en) * | 2003-04-15 | 2004-10-21 | Theraquest Biosciences, Llc | Methods of treating pain and compositions for use therefor |
| RU2237475C1 (ru) * | 2003-06-04 | 2004-10-10 | Открытое акционерное общество "Щелковский витаминный завод" | Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты) |
| US20050065172A1 (en) * | 2003-09-23 | 2005-03-24 | Shah Indukumar G. | Solid dosage form comprising caffeine |
| US20050067163A1 (en) * | 2003-09-25 | 2005-03-31 | George Flint R. | Monobore release for tubing conveyed perforating |
| US7914831B2 (en) | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| EP2248532A1 (en) | 2005-08-09 | 2010-11-10 | Metaproteomics, LLP | Protein kinase modulation by hops and acacia products cross-reference to related applications |
| US8241674B2 (en) | 2007-05-11 | 2012-08-14 | Metaproteomics, Llc | Methods and compositions for heavy metal detoxification |
| US20100190752A1 (en) * | 2008-09-05 | 2010-07-29 | Gruenenthal Gmbh | Pharmaceutical Combination |
| US20110064813A1 (en) * | 2009-09-16 | 2011-03-17 | Charles Vaughn | Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet |
| CA3075292A1 (en) * | 2017-10-20 | 2019-04-25 | Purdue Pharma L.P. | Pharmaceutical dosage forms |
| US12194046B2 (en) | 2021-03-09 | 2025-01-14 | Lennham Pharmaceuticals, Inc. | D9-caffeine compositions and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3439094A (en) * | 1967-07-20 | 1969-04-15 | Warner Lambert Pharmaceutical | Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol |
| US4404210A (en) * | 1982-06-30 | 1983-09-13 | E. I. Du Pont De Nemours And Company | Analgesic mixture of nalbuphine and ibuprofen |
-
1983
- 1983-03-11 US US06/474,358 patent/US4486436A/en not_active Expired - Lifetime
- 1983-07-21 AT AT83902712T patent/ATE29965T1/de not_active IP Right Cessation
- 1983-07-21 CA CA000432885A patent/CA1228544A/en not_active Expired
- 1983-07-21 EP EP87100615A patent/EP0229022A3/en not_active Withdrawn
- 1983-07-21 EP EP83902712A patent/EP0114886B1/en not_active Expired
- 1983-07-21 AU AU18877/83A patent/AU559218B2/en not_active Ceased
- 1983-07-21 WO PCT/US1983/001122 patent/WO1984000490A1/en not_active Ceased
- 1983-07-21 IT IT8322171A patent/IT1206501B/it active
- 1983-07-21 DE DE8383902712T patent/DE3373866D1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0114886A1 (en) | 1984-08-08 |
| DE3373866D1 (en) | 1987-11-05 |
| ATE29965T1 (de) | 1987-10-15 |
| US4486436A (en) | 1984-12-04 |
| EP0229022A3 (en) | 1989-11-08 |
| IT8322171A0 (it) | 1983-07-21 |
| EP0229022A2 (en) | 1987-07-15 |
| AU1887783A (en) | 1984-02-23 |
| EP0114886B1 (en) | 1987-09-30 |
| AU559218B2 (en) | 1987-02-26 |
| CA1228544A (en) | 1987-10-27 |
| WO1984000490A1 (en) | 1984-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU559218B2 (en) | Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same | |
| SE8503762D0 (sv) | Analgetiska och anti-inflammatoriska kompositioner innefattande xantiner och forfarande for anvendning av dessa | |
| DE3586545D1 (de) | Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen. | |
| ATE22007T1 (de) | Pharmazeutische mischung. | |
| DE68901417D1 (de) | Pharmazeutische zusammensetzung. | |
| IT8621358A0 (it) | Composizione farmaceutica adattivita' analgesica. | |
| IT8522800A0 (it) | Composizione effeverscente adattivita' analgesica. | |
| IT1212778B (it) | Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene. | |
| DE3485408D1 (de) | Pharmazeutische zusammensetzung. | |
| DE3777661D1 (de) | Bindemittel-verabreichungseinheit. | |
| DE3486255D1 (de) | Pharmazeutische Zusammensetzungen. | |
| SE8401538L (sv) | Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande koffein och forfaranden for anvendning av dessa | |
| DE3484098D1 (de) | Pharmazeutische zusammensetzungen. | |
| SE8401537D0 (sv) | Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande ibuprofen och sett att anvenda dessa | |
| ATE59286T1 (de) | Pharmazeutische mixtur. | |
| FI893643A0 (fi) | Farmaceutiska kompositioner. | |
| DE3382112D1 (de) | Pharmazeutische zusammensetzung. | |
| DE3682083D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE3784595D1 (de) | Arzneimittel gegen feste tumoren. | |
| FI883673A0 (fi) | Farmaceutiska kompositioner. | |
| DE3674040D1 (de) | Pharmazeutische zusammensetzungen. | |
| IT8323396A0 (it) | Antimuscarinica. composizione farmaceutica adattivita' sistemica anticolinesterasica, agonista-colinergica ed | |
| FI832519A7 (fi) | Farmaseuttisia menetelmiä ja koostumuksia. | |
| DE3483900D1 (de) | Pharmazeutische zusammensetzungen. | |
| IT8123488A0 (it) | Metaboliti, loro preparazione eloro impiego in terapeutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970730 |